Interleukin-17 is a negative regulator of established allergic asthma

Journal of Experimental Medicine

Volumn 203, Issue 12, 2006, Pages 2715-2725

  Schnyder Candrian, Silvia ^a,b   Togbe, Dieudonnée ^a   Couillin, Isabelle ^a   Mercier, Isabelle ^a   Brombacher, Frank ^d   Quesniaux, Valérie ^a   Fossiez, Francois ^c   Ryffel, Bernhard ^a   Schnyder, Bruno ^a,b  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b Biomedical Research Foundation   (Switzerland)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 5; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ALLERGIC ASTHMA; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; EX VIVO STUDY; HELPER CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION;

ALLERGENS; ANIMALS; ASTHMA; CELLS, CULTURED; CHEMOKINES, CC; DENDRITIC CELLS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RANTES;

EID: 33751506710     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061401     Document Type: Article

References (54)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
2. D'Ambrosio, D., A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, A. Mantovani, and F. Sinigaglia. 1998. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161:5111-5115.
3. Herrick, C.A., and K. Bottomly. 2003. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3:405-412.
4. Fossiez, F., J. Banchereau, R. Murray, C. Van Kooten, P. Garrone, and S. Lebecque. 1998. Interleukin-17. Int. Rev. Immunol. 16:541-551.
5. Yao, Z., S.L. Painter, W.C. Fanslow, D. Ulrich, B.M. Macduff, M.K. Spriggs, and R.J. Armitage. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155:5483-5486.
6. Ferretti, S., O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170:2106-2112.
7. Wynn, T.A. 2005. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 6:1069-1070.
8. Moseley, T.A., D.R. Haudenschild, L. Rose, and A.H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-174.
9. Witowski, J., K. Ksiazek, and A. Jorres. 2004. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61:567-579.
10. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver. 2005. Interleukin 17- producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
11. Park, H., Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
12. Ye, P., F.H. Rodriguez, S. Kanaly, K.L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-527.
13. Huang, W., L. Na, P.L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
14. Kelly, M.N., J.K. Kolls, K. Happel, J.D. Schwartzman, P. Schwarzenberger, C. Combe, M. Moretto, and I.A. Khan. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73:617-621.
15. Schwarzenberger, P., W. Huang, P. Ye, P. Oliver, M. Manuel, Z. Zhang, G. Bagby, S. Nelson, and J.K. Kolls. 2000. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 164:4783-4789.
16. Hofstetter, H.H., S.M. Ibrahim, D. Koczan, N. Kruse, A. Weishaupt, K.V. Toyka, and R. Gold. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237:123-130.
17. Lubberts, E., P. Schwarzenberger, W. Huang, J.R. Schurr, J.J. Peschon, W.B. van den Berg, and J.K. Kolls. 2005. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J. Immunol. 175:3360-3368.
18. Koenders, M.I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M.M. Helsen, F.E. Di Padova, A.M. Boots, H. Gram, L.A. Joosten, and W.B. van den Berg. 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167:141-149.
19. Murphy, C.A., C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick, and D.J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-1957.
20. Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748.
21. Zhang, G.X., B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170:2153-2160.
22. Yen, D., J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M.A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-1316.
23. Barczyk, A., W. Pierzchala, and E. Sozanska. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97:726-733.
24. Hashimoto, T., K. Akiyama, N. Kobayashi, and A. Mori. 2005. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137:51-54.
25. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Page, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430-438.
26. Linden, A., and M. Adachi. 2002. Neutrophilic airway inflammation and IL-17. Allergy. 57:769-775.
27. Kolls, J.K., S.T. Kanaly, and A.J. Ramsay. 2003. Interleukin-17: an emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28:9-11.
28. Hellings, P.W., A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J.L. Ceuppens. 2003. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28:42-50.
29. Umetsu, D.T. 2004. Flu strikes the hygiene hypothesis. Nat. Med. 10:232-234.
30. Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179-189.
31. Tsaknaridis, L., L. Spencer, N. Culbertson, K. Hicks, D. LaTocha, Y.K. Chou, R.H. Whitham, A. Bakke, R.E. Jones, H. Offner, et al. 2003. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J. Neurosci. Res. 74:296-308.
32. Buenafe, A.C., L. Tsaknaridis, L. Spencer, K.S. Hicks, R.H. McMahan, L. Watson, N.E. Culbertson, D. Latocha, K. Wegmann, T. Finn, et al. 2004. Specificity of regulatory CD4+CD25+ T cells for self-T cell receptor determinants. J. Neurosci. Res. 76:129-140.
33. Andoh, A., S. Fujino, S. Bamba, Y. Araki, T. Okuno, T. Bamba, and Y. Fujiyama. 2002. IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J. Immunol. 169:1683-1687.
34. Silverman, M.D., D.O. Zamora, Y. Pan, P.V. Texeira, S.H. Baek, S.R. Planck, and J.T. Rosenbaum. 2003. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest. Ophthalmol. Vis. Sci. 44:1608-1615.
35. Kanda, N., S. Koike, and S. Watanabe. 2005. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J. Allergy Clin. Immunol. 116:1144-1150.
36. Schnyder, B., S. Schnyder-Candrian, A. Pansky, M.L. Schmitz, M. Heim, B. Ryffel, and R. Moser. 2005. IL-17 reduces TNF-induced Rantes and VCAM-1 expression. Cytokine. 31:191-202.
37. Kuipers, H., and B.N. Lambrecht. 2004. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr. Opin. Immunol. 16:702-708.
38. Couillin, I., I. Maillet, B.B. Vargaftig, M. Jacobs, G.C. Paesen, P.A. Nuttall, J. Lefort, R. Moser, W. Weston-Davies, and B. Ryffel. 2004. Arthropod-derived histamine-binding protein prevents murine allergic asthma. J. Immunol. 173:3281-3286.
39. Rothenberg, M.E., J.A. MacLean, E. Pearlman, A.D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785-790.
40. Chvatchko, Y., A.E. Proudfoot, R. Buser, P. Juillard, S. Alouani, M. Kosco-Vilbois, A.J. Coyle, R.J. Nibbs, G. Graham, R.E. Offord, and T.N. Wells. 2003. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J. Immunol. 171:5498-5506.
41. Kawasaki, S., H. Takizawa, H. Yoneyama, T. Nakayama, R. Fujisawa, M. Izumizaki, T. Imai, O. Yoshie, I. Homma, K. Yamamoto, and K. Matsushima. 2001. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol. 166:2055-2062.
42. Chatila, T.A. 2004. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol. Med. 10:493-499.
43. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 17:375-387.
44. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173-6177.
45. Schnyder, B., S. Lugli, N. Feng, H. Etter, R.A. Lutz, B. Ryffel, K. Sugamura, H. Wunderli-Allenspach, and R. Moser. 1996. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood. 87:4286-4295.
46. Grunig, G., M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, D. Sheppard, M. Mohrs, D.D. Donaldson, R.M. Locksley, and D.B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:2261-2263.
47. Desmet, C., P. Gosset, B. Pajak, D. Cataldo, M. Bentires-Alj, P. Lekeux, and F. Bureau. 2004. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J. Immunol. 173:5766-5775.
48. Fulkerson, P.C., N. Zimmermann, L.M. Hassman, F.D. Finkelman, and M.E. Rothenberg. 2004. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J. Immunol. 173:7565-7574.
49. Tumas, D.B., B. Chan, W. Werther, T. Wrin, J. Vennari, N. Desjardin, R.L. Shields, and P. Jardieu. 2001. Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization. J. Allergy Clin. Immunol. 107:1025-1033.
50. Pelidou, S.H., L.P. Zou, G. Deretzi, C. Oniding, E. Mix, and J. Zhu. 2000. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Exp. Neurol. 163:165-172.
51. Taylor, G.A., E. Carballo, D.M. Lee, W.S. Lai, M.J. Thompson, D.D. Patel, D.I. Schenkman, G.S. Gilkeson, H.E. Broxmeyer, B.F. Haynes, and P.J. Blackshear. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 4:445-454.
52. Van Oosterhout, A.J., D. Fattah, I. Van Ark, G. Hofman, T.L. Buckley, and F.P. Nijkamp. 1995. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J. Allergy Clin. Immunol. 96:104-112.
53. Schnyder-Candrian, S., V.F. Quesniaux, F. Di Padova, I. Maillet, N. Noulin, I. Couillin, R. Moser, F. Erard, B.B. Vargaftig, B. Ryffel, and B. Schnyder. 2005. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J. Immunol. 175:262-269.
54. Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.